Report: No matter which company you pick, retail pharmacy represents strong investment potential
NEW YORK — The drug store sector makes for a sound investment for investors of all stripes, according to a Motley Fool report published Thursday.
In early morning trading Friday, CVS stock traded at $63.59, up 4 cents; Walgreens at $59.16, down 4 cents; and Rite Aid at $5.17, up 4 cents.
CVS/Caremark is positioned as the safest bet with its two-tiered business strategy leveraging retail pharmacy and pharmacy benefit management.
Walgreens is a sound long-term hold because of its dividend history. Walgreens has paid out a quarterly dividend over consecutive quarters dating back some 80 years. And that dividend has increased for 38 consecutive years.
For those with "a higher risk tolerance," Rite Aid represents a strong growth story. "The company has implement[ed] a remarkable turnaround during recent quarters by controlling costs and introducing more generic drugs to boost sales," Motley Fool wrote. "This has materially increased profitability, and Rite Aid investors have benefited from an explosive gain of more than 290% in the stock price over the last 12 months."
National Pharmaceutical Council elects Boehringer Ingelheim executive as chairman
WASHINGTON — Boehringer Ingelheim SVP managed markets Jeff Huth has been elected by the National Pharmaceutical Council as chairman of the board for 2013-2014, the organization said Friday.
Huth has served as a member of the NPC’s board since 2009 and has previously had the positions of vice chairman and treasurer. The NPC, founded in 1953, describes itself as a health policy research organization focused on the advancement of science and medical innovation.
"Throughout his tenure on our board, Jeff has been dedicated to promoting NPC and its role as a leading healthcare policy research organization," NPC president Dan Leonard said. "We’re looking forward to having Jeff play an even more active role in leading NPC’s efforts on issues related to balancing the needs of patients with the population, the value of pharmaceuticals and the use of real-world evidence."
NACDS’ Anderson: November Health Affairs adds more ‘heft’ to community pharmacy support
ARLINGTON, Va. — The National Association of Chain Drug Stores is hailing articles in the November 2013 edition of Health Affairs that urge greater reliance on pharmacy in new healthcare delivery models and that recommend re-alignment of federal and state policies to empower pharmacy patient care.
“Articles in this edition of Health Affairs read like a playbook for leveraging the value, expertise and accessibility of community pharmacies, for the good of patients nationwide,” stated NACDS president and CEO Steve Anderson. “Pharmacists are well-known for helping patients use medicines and stay healthy, and we are seeing greater and greater awareness of the innovative pharmacy services that can do even more to improve patient health and quality of life.”
With a theme of “Redesigning the Health Care Workforce,” the November 2013 Health Affairs includes articles on the role of pharmacists in accountable care organizations and other new healthcare delivery models; on the need to restructure scope-of-practice regulations for health professions; and on strategies to address the physician shortage.
“This edition of Health Affairs adds even more heft to the mounting support for the vision that pharmacies should be empowered to help shape the healthcare delivery system of tomorrow, in partnership with doctors, nurses and other allies in patient care. It builds on the substantial case for leveraging pharmacy’s strengths as the face of neighborhood health care,” Anderson stated.